Cody HS 3rd, Fey J., Akhurst T., et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol.2001;8:13-19.
2.
Fortunato L. , Amini M., Farina M., et al. Intraoperative examination of sentinel nodes in breast cancer: is the glass half full or half empty? Ann Surg Oncol. 2004;11: 1005-1010.
3.
Green M., Farshid G., Kollias J., Chatterton BE, Tsopelas C.The tissue distribution of Evans blue dye in a sheep model of sentinel node biopsy. Nucl Med Commun. 2006;27: 695-700.
4.
Goyal A., Mansel RERecent advances in sentinel lymph node biopsy for breast cancer. Curr Opin Oncol. 2008;20:621-626.
5.
Peng Y., Ashfaq R., Ewing G., Leitch AM, Molberg KHFalse-positive sentinel lymph nodes in breast cancer patients caused by benign glandular inclusions: report of three cases and review of the literature. Am J Clin Pathol. 2008;130:21-27.
6.
Norton LE, Komenaka IK, Emerson RE, Murphy C., Badve S.Benign glandular inclusions a rare cause of a false positive sentinel node . J Surg Oncol. 2007;95: 593-596.
7.
Scognamiglio T., Hoda RS, Edgar MA, Hoda SAThe need for vigilance in the pathologic evaluation of sentinel lymph nodes: a report of two illustrative cases. Breast J. 2003;9:420-422.
8.
Guerrero-Medrano J., Delgado R., Albores-Saavedra J.Signet-ring sinus histiocytosis: a reactive disorder that mimics metastatic adenocarcinoma. Cancer. 1997;80: 277-285.